Foundation for innovation
in Cardiometabolism and Nutrition

IHU-ICAN

Communication

TRaining

clinical TEams

Cardiometabolism

INnovative care Pathways

Reference Centers

Research Teams

research

research focus Area

Our Support

clinical Investigation

scientific Plateforms

Parterships

Why Support ICAN?

How to support ICAN?

projects to Support

Research

  • The ICONIC project: creation of the 1st atlas of cardiac and hepatic imaging in the general population, including people under the age of 40

    The ICONIC project: creation of the 1st atlas of cardiac and hepatic imaging in the general population, including people under the age of 40

    Read More
  • Combating the cardiovascular risk of homozygous familial hypercholesterolemia: the IDEAL-HFHo project

    Combating the cardiovascular risk of homozygous familial hypercholesterolemia: the IDEAL-HFHo project

    Read More
  • ICAN Scientific Day 2025 on Cardiometabolic Diseases

    ICAN Scientific Day 2025 on Cardiometabolic Diseases

    ,
    Read More
  • What are the key takeaways from the symposium on cardiometabolic diseases at the Academy of Medicine?

    What are the key takeaways from the symposium on cardiometabolic diseases at the Academy of Medicine?

    , ,
    Read More
  • IHU ICAN’s flagship actions in 2024 to combat cardiometabolic diseases

    IHU ICAN’s flagship actions in 2024 to combat cardiometabolic diseases

    , , , , , ,
    Read More
  • Discovery of the link between CD63 tetraspanin and cholesterol transport

    Discovery of the link between CD63 tetraspanin and cholesterol transport

    Read More
  • Epicardial adipose tissue discovery: better prevention of atrial metabolic cardiomyopathy with MRI

    Epicardial adipose tissue discovery: better prevention of atrial metabolic cardiomyopathy with MRI

    Read More
  • Results of the MAESTRO-NASH clinical trial: a new hope for the treatment of MASH (NASH) with liver fibrosis

    Results of the MAESTRO-NASH clinical trial: a new hope for the treatment of MASH (NASH) with liver fibrosis

    Read More
  • A new diagnostic tool to improve MASH (NASH) clinical trials

    A new diagnostic tool to improve MASH (NASH) clinical trials

    Read More
  • MEDITWIN: using digital twins to develop tomorrow’s personalized medicine

    MEDITWIN: using digital twins to develop tomorrow’s personalized medicine

    , ,
    Read More

Stay in touch

Get all the latest news from the ICAN Foundation

This field is for validation purposes and should be left unchanged.

OUr founders

ISO 9001 Certified

OUr Institutionnal Supporters

Our network